Our study demonstrated ARNTL, CRY2, BHLHE41 and NPAS2 as potential biomarkers of circadian rhythm in HF, with the potential to provide novel markers or targets for the diagnosis and treatment of HF. Here, CRY2 is linked to hydrops fetalis.